Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer

A 75-year-old man with stage IV lung adenocarcinoma was treated with osimertinib due to disease progression despite having been administered erlotinib. Both an epidermal growth factor receptor (EGFR) L858R mutation on exon 21 and a T790M mutation on exon 20 were detected in a specimen from a recurre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Intern Med
Main Authors: Matsumoto, Yoshiya, Kawaguchi, Tomoya, Yamamoto, Norio, Sawa, Kenji, Yoshimoto, Naoki, Suzumura, Tomohiro, Watanabe, Tetsuya, Mitsuoka, Shigeki, Asai, Kazuhisa, Kimura, Tatsuo, Yoshimura, Naruo, Kuwae, Yuko, Hirata, Kazuto
Format: Artigo
Jezik:Inglês
Izdano: The Japanese Society of Internal Medicine 2017
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5635308/
https://ncbi.nlm.nih.gov/pubmed/28794368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8467-16
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki